Join
Live feed
·
PRReleasevia Quantisnow
Equillium Inc. logo

Equillium and Ono Pharmaceutical Announce Exclusive Option and Asset Purchase Agreement for the Development and Commercialization of Itolizumab

ByQuantisnow·Wall Street's wire, on your screen.
EQ· Equillium Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track EQ (Equillium Inc.) and more on Quantisnow.